ABB Ltd. News and Industrial Automation & Electrification Updates

70.84
1.6600
2.29 %
Daily range
Weekly range
  • Dmytro Kharkov
  • 27.10.2026
AbbVie growth drugs support stock buy case as Humira transition eases
AbbVie is entering a new phase of expansion as newer medicines offset the long decline in Humira sales and add momentum across key therapy areas. The company’s immunology and neuroscience ...
  • Daria Chernytska
  • 21.10.2026
Abbott Laboratories to spin off nutrition unit amid formula litigation pressure
Abbott Laboratories is moving to separate its nutrition business into a standalone public company as the division faces litigation and operational strain tied to the baby formula market. The unit ...
  • Anastasiia Chabaniuk
  • 20.10.2026
ABB data centre orders surge as third-quarter earnings track forecasts
Demand linked to artificial intelligence infrastructure continues to support ABB's growth in electrification and automation markets. The Swiss engineering group says orders for data centre ...
  • Jainam Mehta
  • 18.10.2026
Europe industrial groups split AI investment strategies
Europe’s biggest industrial companies are channeling gains from the AI-driven data centre boom into sharply different acquisition and product strategies. Schneider Electric and Siemens are ...
  • Dmytro Kharkov
  • 29.09.2026
UMS Integration suspends share trading on Bursa Malaysia pending an announcement
Trading in UMS Integration Ltd shares on Bursa Malaysia was suspended throughout Tuesday's session after the company requested a temporary halt. The move comes as the high-precision engineering ...
  • Ciaran Ryan
  • 05.08.2026
U.S. healthcare stocks attract inflows as investors rotate beyond tech
A broader market rotation is lifting U.S. healthcare shares as investors look for sectors with stronger earnings prospects and lower valuation risk. The shift comes after years of underperformance ...
  • Ashutosh Sureka
  • 17.07.2026
London market faces renewed foreign takeover wave as UK listings thin
Foreign takeovers of London-listed companies are continuing as low valuations and international business exposure keep attracting overseas buyers. The trend is intensifying at a time when only ...
  • Dan Blystone
  • 16.07.2026
ABB to buy UK-based Rotork in £4.1bn automation deal
Foreign takeovers of London-listed companies continue to gather pace as overseas buyers target UK groups with lower valuations and international operations. In that backdrop, Swiss engineering ...
  • Dan Blystone
  • 30.06.2026
U.S. House committee opens China trial probe into Merck and AbbVie
Heightened U.S. scrutiny of China's biotechnology sector is widening to pharmaceutical research, as House lawmakers investigate whether clinical trials by Merck and AbbVie in China create ethical ...